Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Viemed Healthcare (VMD) Net Margin (2018 - 2026)

Viemed Healthcare filings provide 8 years of Net Margin readings, the most recent being 7.63% for Q4 2025.

  • On a quarterly basis, Net Margin rose 35.0% to 7.63% in Q4 2025 year-over-year; TTM through Dec 2025 was 5.69%, a 60.0% increase, with the full-year FY2025 number at 5.69%, up 60.0% from a year prior.
  • Net Margin hit 7.63% in Q4 2025 for Viemed Healthcare, up from 5.01% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 12.79% in Q4 2021 to a low of 2.69% in Q2 2024.
  • Median Net Margin over the past 5 years was 5.59% (2021), compared with a mean of 5.63%.
  • Biggest five-year swings in Net Margin: crashed -3958bps in 2021 and later soared 296bps in 2023.
  • Viemed Healthcare's Net Margin stood at 12.79% in 2021, then plummeted by -49bps to 6.5% in 2022, then rose by 5bps to 6.85% in 2023, then rose by 6bps to 7.29% in 2024, then increased by 5bps to 7.63% in 2025.
  • The last three reported values for Net Margin were 7.63% (Q4 2025), 5.01% (Q3 2025), and 5.15% (Q2 2025) per Business Quant data.